Investing.com - CONMED (NYSE: CNMD) reported fourth quarter EPS of $1.06, $0.05 worse than the analyst estimate of $1.11. Revenue for the quarter came in at $327M versus the consensus estimate of $332.22M.
Guidance
CONMED sees FY 2024 EPS of $4.30-$4.40 versus the analyst consensus of $4.40.
CONMED sees FY 2024 revenue of $1.34B-$1.37B versus the analyst consensus of $1.36B.
CONMED's stock price closed at $95.64. It is down -6.43% in the last 3 months and down -3.68% in the last 12 months.
https://in.investing.com/news/conmed-earnings-missed-by-005-revenue-fell-short-of-estimates-3997021
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.